These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34758142)

  • 21. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
    Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
    Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous glucose monitoring reduces both hypoglycaemia and HbA1c in hypoglycaemia-prone type 1 diabetic patients treated with a portable pump.
    Radermecker RP; Saint Remy A; Scheen AJ; Bringer J; Renard E
    Diabetes Metab; 2010 Nov; 36(5):409-13. PubMed ID: 20864372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of short-term real-time continuous glucose monitoring in type 1 diabetes patients on continuous intraperitoneal insulin infusion: a feasibility study.
    Logtenberg SJ; Kleefstra N; Groenier KH; Gans RO; Bilo HJ
    Diabetes Technol Ther; 2009 May; 11(5):293-9. PubMed ID: 19425877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical efficacy of Professional Continuous Glucose Monitoring in improving glycemic control among children with Type 1 Diabetes Mellitus: An Open-label Randomized Control Trial.
    Raviteja KV; Kumar R; Dayal D; Sachdeva N
    Sci Rep; 2019 Apr; 9(1):6120. PubMed ID: 30992480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous glucose monitoring in hemodialyzed patients with type 2 diabetes: a multicenter pilot study.
    Képénékian L; Smagala A; Meyer L; Imhoff O; Alenabi F; Serb L; Fleury D; Dorey F; Krummel T; Le Floch JP; Chantrel F; Kessler L
    Clin Nephrol; 2014 Oct; 82(4):240-6. PubMed ID: 25161114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamics of Hemoglobin A1c, Body Mass Index, and Rates of Severe Hypoglycemia in 4434 Adults with Type 1 or Type 2 Diabetes After Initiation of Continuous Glucose Monitoring.
    Lanzinger S; Best F; Bergmann T; Laimer M; Lipovsky B; Danne T; Zimny S; Bramlage P; Meyhöfer S; Holl RW
    Diabetes Technol Ther; 2022 Oct; 24(10):763-769. PubMed ID: 35653726
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls.
    Nathanson D; Svensson AM; Miftaraj M; Franzén S; Bolinder J; Eeg-Olofsson K
    Diabetologia; 2021 Jul; 64(7):1595-1603. PubMed ID: 33774713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Association Between HbA
    Seyed Ahmadi S; Westman K; Pivodic A; Ólafsdóttir AF; Dahlqvist S; Hirsch IB; Hellman J; Ekelund M; Heise T; Polonsky W; Wijkman M; Schwarcz E; Lind M
    Diabetes Care; 2020 Sep; 43(9):2017-2024. PubMed ID: 32641374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study.
    Charleer S; Mathieu C; Nobels F; De Block C; Radermecker RP; Hermans MP; Taes Y; Vercammen C; T'Sjoen G; Crenier L; Fieuws S; Keymeulen B; Gillard P;
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1224-1232. PubMed ID: 29342264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.
    Heinemann L; Freckmann G; Ehrmann D; Faber-Heinemann G; Guerra S; Waldenmaier D; Hermanns N
    Lancet; 2018 Apr; 391(10128):1367-1377. PubMed ID: 29459019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relation between HbA1c and hypoglycemia revisited; a secondary analysis from an intervention trial in patients with type 1 diabetes and impaired awareness of hypoglycemia.
    van Beers CAJ; Caris MG; DeVries JH; Serné EH
    J Diabetes Complications; 2018 Jan; 32(1):100-103. PubMed ID: 29054335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized controlled pilot study of continuous glucose monitoring and flash glucose monitoring in people with Type 1 diabetes and impaired awareness of hypoglycaemia.
    Reddy M; Jugnee N; El Laboudi A; Spanudakis E; Anantharaja S; Oliver N
    Diabet Med; 2018 Apr; 35(4):483-490. PubMed ID: 29230878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
    Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
    Bosi E; Choudhary P; de Valk HW; Lablanche S; Castañeda J; de Portu S; Da Silva J; Ré R; Vorrink-de Groot L; Shin J; Kaufman FR; Cohen O;
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):462-472. PubMed ID: 31047902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study.
    Blackberry ID; Furler JS; Ginnivan LE; Manski-Nankervis JA; Jenkins A; Cohen N; Best JD; Young D; Liew D; Ward G; O'Neal DN
    Diabetes Res Clin Pract; 2014 Nov; 106(2):247-55. PubMed ID: 25271117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimization of insulin regimen and glucose outcomes with short-term real-time continuous glucose monitoring (RT-CGM) in type 1 diabetic children with sub-optimal glucose control on multiple daily injections: The pediatric DIACCOR study.
    Picard S; Bonnemaison-Gilbert E; Leutenegger E; Barat P
    Arch Pediatr; 2019 Feb; 26(2):95-101. PubMed ID: 30642746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of Insulin Regimen and Glucose Outcomes with Short-Term Real-Time Continuous Glucose Monitoring in Adult Type 1 Diabetes Patients with Suboptimal Control on Multiple Daily Injections: The Adult DIACCOR Study.
    Picard S; Hanaire H; Reznik Y; Benhamou PY; Fendri S; Dufaitre L; Leutenegger E; Guerci B
    Diabetes Technol Ther; 2018 Jun; 20(6):403-412. PubMed ID: 29847735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revisiting the Relationships Between Measures of Glycemic Control and Hypoglycemia in Continuous Glucose Monitoring Data Sets.
    Gimenez M; Tannen AJ; Reddy M; Moscardo V; Conget I; Oliver N
    Diabetes Care; 2018 Feb; 41(2):326-332. PubMed ID: 29191845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.